NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

臨床決策支援系統 (CDSS)的全球市場 (∼2025年): 各零組件 (服務、軟體)、部署模式、產品、用途、模式 (知識為基礎)、類型 (治療、診斷)、作用 (活性、被動式)、患者照護網站、地區

Clinical Decision Support Systems/CDSS Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive),Patient Care Setting - Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 976028
出版日期 內容資訊 英文 197 Pages
訂單完成後即時交付
價格
臨床決策支援系統 (CDSS)的全球市場 (∼2025年): 各零組件 (服務、軟體)、部署模式、產品、用途、模式 (知識為基礎)、類型 (治療、診斷)、作用 (活性、被動式)、患者照護網站、地區 Clinical Decision Support Systems/CDSS Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive),Patient Care Setting - Global Forecast to 2025
出版日期: 2020年12月09日內容資訊: 英文 197 Pages
簡介

全球臨床決策支援系統 (CDSS)的市場規模在預測期間內預計以9.1%的年複合成長率發展,從2020年的12億美元,成長到2025年18億美元的規模。推動引進HIT解決方案的政策、舉措的實施,CDSS支援EHR的採用增加,相關利益者間的聯盟、合作數量增加,醫療錯誤的發生率增加,對行動醫療及巨量資料工具的關注度擴大等要素促進該市場成長。同時,預計實行成本高和互通性和資料安全相關疑慮妨礙市場進一步成長。

本報告提供全球臨床決策支援系統 (CDSS)的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,技術趨勢,市場規模的變化、預測,零組件、產品、類型、模式、部署模式、用途、作用、患者照護網站、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19的影響
  • 生態系統分析
  • 技術分析

第6章 市場分析、預測:各零件

  • 服務
  • 軟體
  • 硬體設備

第7章 市場分析、預測:各產品

  • 整合型CDSS
  • 獨立式CDSS

第8章 市場分析、預測:各類型

  • 治療用CDSS
  • 診斷用CDSS

第9章 市場分析、預測:各模式

  • 知識為基礎的CDSS
  • 非知識為基礎的CDSS

第10章 市場分析、預測:各部署模式

  • 內部部署
  • 雲端

第11章 市場分析、預測:各用途

  • 傳統CDSS
  • 先進型CDSS

第12章 市場分析、預測:各作用

  • 主動式CDSS
  • 被動式CDSS

第13章 市場分析、預測:各患者照護網站

  • 住院患者
  • 門診病人診療

第14章 市場分析、預測:各地區、主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第15章 競爭情形

  • 概要
  • 企業排行榜
  • 企業評估矩陣
  • 競爭模式

第16章 企業簡介

  • CERNER
  • CHANGE HEALTHCARE
  • EPIC SYSTEMS
  • MEDITECH
  • PHILIPS HEALTHCARE
  • WOLTERS KLUWER HEALTH
  • ZYNX HEALTH
  • ELSEVIER B.V.
  • IBM WATSON HEALTH
  • ALLSCRIPTS HEALTHCARE SOLUTIONS
  • ATHENAHEALTH, INC.
  • NEXTGEN HEALTHCARE
  • SIEMENS HEALTHINEERS
  • ESCBO HEALTH
  • GE HEALTHCARE
  • ECLINICALWORKS
  • RAMPMEDICAL
  • MEDICAL ALGORITHMS COMPANY
  • HERA-MI
  • CUREMD
  • MTBC

第17章 附錄

目錄
Product Code: HIT 2237

The global clinical decision support system market is expected to reach USD 1.8 billion by 2025 from an estimated USD 1.2 billion in 2020 at a CAGR of 9.1% during the forecast period. The key factors propelling the growth of this market are the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, increasing number of collaborations and partnerships between stakeholders, growing incidence of medication errors, and the rising prominence of mHealth and big data tools. However, the high investment requirements for the implementation of CDSS and the lack of interoperability and data security concerns are expected to restrain the growth of this market during the forecast period.

Integrated CDSS is widely used by healthcare providers as it improves the quality of care

On the basis of product, the clinical decision support systems market is segmented into integrated CDSS and standalone CDSS. In 2019, the integrated CDSS segment accounted for the largest share of 70.4% of the market. This segment is projected to reach USD 1,384.8 million by 2025 from USD 859.2 million in 2020, at a CAGR of 10.0%. The large share of this segment can be attributed to the high and growing deployment of integrated CDSS.

Knowledge-based CDSS can provide reasoning in the face of uncertainties which is often required of CDSS solutions

On the basis of the system model, the market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2019, the knowledge-based CDSS segment accounted for the largest share of ~59% of the market. This segment is also estimated to register the highest CAGR of 10.2% during the forecast period. The large share and high growth of this segment can be attributed to the several beneficial functionalities of knowledge-based CDSS, such as helping clinicians with knowledge-based reasoning to make clinical decisions in the face of uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors as compared to non-knowledge-based systems.

Asia Pacific to witness significant growth from 2020 to 2025

Geographically, the clinical decision support systems market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The market in the APAC is expected to grow at the highest CAGR over the next five years. Factors such as the presence of a large geriatric population, improved government legislation, high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 - 45%, Tier 2 - 35%, and Tier 3 - 20% * By Designation: C-level - 26%, Director-level - 17%, and Others - 57% * By Region: North America - 40%, Europe - 20%, APAC - 30%, Latin America - 6%, and Middle East - 4%

Some of the major market players in the clinical decision support systems market are Cerner (US), Epic (US), MEDITECH (US), Wolters Kluwer Health (Netherlands), Zynx Health (US), Elsevier B.V. (Netherlands), IBM Watson Health (US), Allscripts Healthcare Solutions (US), NextGen Healthcare (US), and Siemens Healthineers (Germany).

Research Coverage

This report studies the clinical decision support system s market based on product, application, delivery mode, model, type, interactivity, settings. component and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 CDSS MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE REPORT
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY STEPS
    • FIGURE 2 RESEARCH METHODOLOGY: CDSS MARKET
    • FIGURE 3 RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 PRIMARY SOURCES
      • 2.2.2.1 Key primary insights
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 7 MARKET SIZE ESTIMATION
  • 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 COVID-19-SPECIFIC ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020 VS. 2025 (USD MILLION)
    • FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2020 VS. 2025 (USD MILLION)
    • FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020 VS. 2025 (USD MILLION)
    • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
    • FIGURE 18 GOVERNMENT INITIATIVES FOR THE ADOPTION OF HCIT SOLUTIONS TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
    • FIGURE 19 US DOMINATED THE NORTH AMERICAN MARKET IN 2019
  • 4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY PRODUCT
    • FIGURE 20 INTEGRATED CDSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Implementation of government regulations and initiatives to promote the adoption of HIT solutions
      • 5.2.1.2 Increasing adoption of CDSS-enabled EHRs
      • 5.2.1.3 Rising number of collaborations and partnerships between stakeholders
    • TABLE 1 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2018-2020
      • 5.2.1.4 Growing incidence of medication errors
      • 5.2.1.5 Rising prominence and usage of big data and mHealth tools
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Data security concerns related to cloud-based CDSS
      • 5.2.2.2 Lack of interoperability
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging Asian countries
      • 5.2.3.2 Technological advancements and social media integration
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Requirement of high investments in infrastructure for implementing CDSS
      • 5.2.4.2 Dearth of skilled IT professionals in the healthcare industry
  • 5.3 IMPACT OF COVID-19 ON THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
    • FIGURE 23 PRE-COVID-19 AND POST-COVID-19 SCENARIO: CDSS MARKET
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 TECHNOLOGY ANALYSIS
    • TABLE 2 TECHNOLOGICAL DEVELOPMENTS BY SOME LEADING VENDORS

6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 3 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
  • 6.2 SERVICES
    • 6.2.1 SERVICES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
    • TABLE 4 CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 SOFTWARE
    • 6.3.1 THE USE OF EMR/EHR-INTEGRATED CDSS ENABLES ACCESS TO CENTRALIZED PATIENT DATABASES
    • TABLE 5 CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 6.4 HARDWARE
    • 6.4.1 HARDWARE NEEDS TO BE FREQUENTLY UPGRADED OR REPLACED TO MAKE OPTIMAL USE OF THE LATEST SOFTWARE
    • TABLE 6 CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION, 2018-2025 (USD MILLION)

7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 7.2 INTEGRATED CDSS
    • 7.2.1 INTEGRATED CDSS IS WIDELY USED BY HEALTHCARE PROVIDERS AS IT IMPROVES THE QUALITY OF CARE
    • TABLE 8 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 STANDALONE CDSS
    • 7.3.1 STANDALONE CDSS SEGMENT TO ACCOUNT FOR A LOWER SHARE OF THE MARKET
    • TABLE 9 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)

8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE

  • 8.1 INTRODUCTION
    • TABLE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 8.2 THERAPEUTIC CDSS
    • 8.2.1 THERAPEUTIC CDSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
    • TABLE 11 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 DIAGNOSTIC CDSS
    • 8.3.1 DIAGNOSTIC CDSS GUIDES PHYSICIANS THROUGH THE SYSTEMATIC DIFFERENTIAL DIAGNOSIS PROCESS
    • TABLE 12 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)

9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL

  • 9.1 INTRODUCTION
    • TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
  • 9.2 KNOWLEDGE-BASED CDSS
    • 9.2.1 KNOWLEDGE-BASED CDSS CAN PROVIDE REASONING IN THE FACE OF UNCERTAINTIES WHICH IS OFTEN REQUIRED OF CDSS SOLUTIONS
    • TABLE 14 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 NON-KNOWLEDGE-BASED CDSS
    • 9.3.1 NON-KNOWLEDGE-BASED CDSS TO ACCOUNT FOR A LOWER SHARE OF THE MARKET
    • TABLE 15 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)

10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE

  • 10.1 INTRODUCTION
    • TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
  • 10.2 ON-PREMISE CDSS
    • 10.2.1 ON-PREMISE CDSS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
    • TABLE 17 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.3 CLOUD-BASED CDSS
    • 10.3.1 CLOUD-BASED CDSS SEGMENT TO WITNESS HIGH GROWTH IN THE COMING YEARS
    • TABLE 18 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)

11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
    • TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 11.2 CONVENTIONAL CDSS
    • 11.2.1 CONVENTIONAL CDSS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
    • TABLE 20 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 11.3 ADVANCED CDSS
    • 11.3.1 ADVANCED CDSS SEGMENT TO WITNESS HIGH GROWTH IN THE COMING YEARS
    • TABLE 21 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)

12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY

  • 12.1 INTRODUCTION
    • TABLE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
  • 12.2 ACTIVE CDSS
    • 12.2.1 ACTIVE CDSS IS THE LARGEST AND THE FASTEST-GROWING SEGMENT IN THE CDSS MARKET
    • TABLE 23 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 12.3 PASSIVE CDSS
    • 12.3.1 PASSIVE CDSS CAUSES MINIMAL DISRUPTION TO WORKFLOWS
    • TABLE 24 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)

13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING

  • 13.1 INTRODUCTION
    • TABLE 25 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
  • 13.2 INPATIENT SETTINGS
    • 13.2.1 INPATIENT SETTINGS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
    • TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 2018-2025 (USD MILLION)
  • 13.3 AMBULATORY CARE SETTINGS
    • 13.3.1 RISING NEED TO CONTROL THE COST OF HEALTHCARE TO DRIVE THE DEMAND FOR CDSS IN AMBULATORY CARE SETTINGS
    • TABLE 27 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2018-2025 (USD MILLION)

14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION

  • 14.1 INTRODUCTION
    • FIGURE 24 NORTH AMERICA TO DOMINATE THE CDSS MARKET DURING THE FORECAST PERIOD
    • TABLE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 14.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: CDSS MARKET SNAPSHOT
    • TABLE 29 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 30 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 31 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 32 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 33 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 34 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 37 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.2.1 US
      • 14.2.1.1 US is the largest market for CDSS solutions
    • TABLE 38 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 39 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 40 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 41 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 42 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 43 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 45 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.2.2 CANADA
      • 14.2.2.1 Growing need for cost containment to propel market growth
    • TABLE 46 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 47 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 48 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 49 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 50 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 51 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 53 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
  • 14.3 EUROPE
    • TABLE 54 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 56 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 57 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 58 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 59 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 62 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.3.1 GERMANY
      • 14.3.1.1 Government initiatives to boost the adoption of EMRs will drive market growth
    • TABLE 63 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 64 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 65 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 66 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 67 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 68 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 70 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.3.2 UK
      • 14.3.2.1 Favorable government initiatives to drive market growth
    • TABLE 71 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 72 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 73 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 74 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 75 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 76 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 77 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 78 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.3.3 FRANCE
      • 14.3.3.1 Rising focus on improving the healthcare system in the country to drive market growth
    • TABLE 79 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 80 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 81 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 82 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 83 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 84 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 85 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 86 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.3.4 ITALY
      • 14.3.4.1 Growing burden of chronic diseases is driving the demand for CDSS in the country
    • TABLE 87 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 88 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 89 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 90 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 91 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 92 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 93 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 94 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.3.5 SPAIN
      • 14.3.5.1 Growing cases of COVID-19 to support the adoption of CDSS
    • TABLE 95 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 96 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 97 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 98 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 99 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 100 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 101 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 102 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.3.6 REST OF EUROPE
    • TABLE 103 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 104 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 105 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 106 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 107 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 108 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 109 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 110 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
  • 14.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: CDSS MARKET SNAPSHOT
    • TABLE 111 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 112 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 113 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 114 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 115 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 116 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 117 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 118 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 119 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.4.1 JAPAN
      • 14.4.1.1 Rising geriatric population in Japan to support market growth
    • TABLE 120 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 121 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 122 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 123 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 124 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 125 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 126 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 127 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.4.2 CHINA
      • 14.4.2.1 China is a lucrative market for HCIT solutions due to strong government support for healthcare reforms
    • TABLE 128 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 129 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 130 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 131 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 132 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 133 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 134 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 135 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.4.3 INDIA
      • 14.4.3.1 High burden of chronic diseases to support market growth
    • TABLE 136 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 137 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 138 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 139 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 140 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 141 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 142 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 143 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.4.4 REST OF ASIA PACIFIC
    • TABLE 144 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 145 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 146 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 147 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 148 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 149 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 150 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 151 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
  • 14.5 REST OF THE WORLD
    • TABLE 152 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 153 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 154 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 155 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 156 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 157 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 158 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 159 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 160 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.5.1 LATIN AMERICA
      • 14.5.1.1 Developments in healthcare infrastructure to support market growth
    • TABLE 161 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 162 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 163 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 164 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 165 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 166 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 167 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 168 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)
    • 14.5.2 MIDDLE EAST AND AFRICA
      • 14.5.2.1 Growing medical tourism to support market growth in the Middle East & Africa
    • TABLE 169 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2018-2025 (USD MILLION)
    • TABLE 170 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION)
    • TABLE 171 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 172 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 173 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2018-2025 (USD MILLION)
    • TABLE 174 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2018-2025 (USD MILLION)
    • TABLE 175 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 176 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2018-2025 (USD MILLION)

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
    • FIGURE 27 MARKET EVALUATION FRAMEWORK, 2017-2020
    • FIGURE 28 KEY DEVELOPMENTS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
  • 15.2 MARKET RANKING OF PLAYERS, 2019
  • 15.3 COMPANY EVALUATION MATRIX
    • 15.3.1 INTRODUCTION
    • 15.3.2 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
    • TABLE 177 COMPANY EVALUATION MATRIX: EVALUATION CRITERIA
    • 15.3.3 STARS
    • 15.3.4 EMERGING LEADERS
    • 15.3.5 PARTICIPANTS
    • 15.3.6 PERVASIVE
    • FIGURE 29 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATION MATRIX, 2019
  • 15.4 COMPETITIVE SCENARIO
    • 15.4.1 PRODUCT LAUNCHES
    • TABLE 178 KEY PRODUCT LAUNCHES
    • 15.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • TABLE 179 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 15.4.3 ACQUISITIONS
    • TABLE 180 KEY ACQUISITIONS
    • 15.4.4 EXPANSIONS
    • TABLE 181 KEY EXPANSIONS

16 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MNM View)**

  • 16.1 CERNER
    • FIGURE 30 CERNER: COMPANY SNAPSHOT (2019)
  • 16.2 CHANGE HEALTHCARE
    • FIGURE 31 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2019)
  • 16.3 EPIC SYSTEMS
  • 16.4 MEDITECH
    • FIGURE 32 MEDITECH: COMPANY SNAPSHOT (2019)
  • 16.5 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS ELECTRONICS)
    • FIGURE 33 PHILIPS: COMPANY SNAPSHOT (2019)
  • 16.6 WOLTERS KLUWER HEALTH
    • FIGURE 34 WOLTERS KLUWER: COMPANY SNAPSHOT (2019)
  • 16.7 ZYNX HEALTH
  • 16.8 ELSEVIER B.V. (A DIVISION OF RELX GROUP)
  • 16.9 IBM WATSON HEALTH
    • FIGURE 35 IBM: COMPANY SNAPSHOT (2019)
  • 16.10 ALLSCRIPTS HEALTHCARE SOLUTIONS
    • FIGURE 36 ALLSCRIPTS HEALTHCARE SOLUTIONS: COMPANY SNAPSHOT (2019)
  • 16.11 ATHENAHEALTH, INC.
  • 16.12 NEXTGEN HEALTHCARE
    • FIGURE 37 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2019)
  • 16.13 SIEMENS HEALTHINEERS
    • FIGURE 38 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
  • 16.14 ESCBO HEALTH (A DIVISION OF ESCBO INDUSTRIES, INC.)
  • 16.15 GE HEALTHCARE
    • FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
  • 16.16 ECLINICALWORKS
  • 16.17 RAMPMEDICAL
  • 16.18 MEDICAL ALGORITHMS COMPANY
  • 16.19 HERA-MI
  • 16.20 CUREMD
  • 16.21 MTBC
    • FIGURE 40 MTBC: COMPANY SNAPSHOT (2019)

*Details on Business Overview, Products Offered, Recent Developments, and MNM View might not be captured in case of unlisted companies.

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 AVAILABLE CUSTOMIZATIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS